Your institution may have access to this item. Find your institution then sign in to continue.
Title
Long-Term Metabolic Consequences of Switching from Protease Inhibitors to Efavirenz in Therapy for Human Immunodeficiency Virus—Infected Patients with Lipoatrophy.
Authors
Estrada, V.; de Villar, N. G. P.; Martinez Larrad, M. L.; Gonzalez Lopez, A.; Fernandez, C.; Serrano-Rios, M.